Leveraging Home Health Aides to Improve Outcomes in Heart Failure
Leveraging Home Health Aides to Improve Outcomes in Heart Failure: A Pilot Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Madeline R Sterling, MD, MPH, MS
- Phone Number: 6469625029
- Email: mrs9012@med.cornell.edu
Study Locations
-
-
New York
-
New York, New York, United States, 10017
- VNS Health Partners in Care
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Home health aide employed at VNS Health Partners in Care home care agency.
- 1 or more years of experience as a home health aide.
- Speak English or Spanish.
- Assigned to care for an adult admitted to home care with a primary diagnosis of heart failure.
Exclusion Criteria:
- Doesn't meet inclusion criteria.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Enhanced usual care
Home health aides in the enhanced usual care arm will receive a virtual heart failure training course.
|
Virtual training course on heart failure for home health aides.
|
|
Experimental: Intervention arm
Home health aides in the intervention arm will receive a virtual heart failure training course and a communication-based messaging app.
|
Virtual training course on heart failure for home health aides.
The mHealth app will provide heart failure-specific education to home health aides and allow them to report clinical observations and ask nurses questions in real-time.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Heart Failure Knowledge
Time Frame: Baseline (0 days); at follow-up (90 days)
|
As measured by the Dutch Heart Failure Knowledge Scale, scores range from 0-15; higher scores indicate greater heart failure knowledge.
|
Baseline (0 days); at follow-up (90 days)
|
|
Change in Heart Failure Caregiving Self-efficacy
Time Frame: Baseline (0 days); at follow-up (90 days)
|
As measured by the Caregiver Contribution to Self-Care in Heart Failure Index, which is a 22-item scale which assesses maintenance, management, and self-efficacy sub-scales separately.
Each sub-scale score ranges from 0-100, with greater scores indicating greater contribution to care or self-efficacy.
|
Baseline (0 days); at follow-up (90 days)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Job Satisfaction
Time Frame: Baseline (0 days); at follow-up (90 days)
|
As measured by the Work Domain Satisfaction Scale, which is a 5-item scale that measures: 1) job satisfaction among care workers; and 2) examines the associations with work environment factors, work stressors, and health issues.
Scores range from 5-20, with higher scores indicating stronger satisfaction.
|
Baseline (0 days); at follow-up (90 days)
|
|
Change in Intention to Leave
Time Frame: Baseline (0 days); at follow-up (90 days)
|
As measured by the Turnover Intention Scale, which is a 2-item scale that measures workers' intentions of 1) leaving their current job (at their agency) and 2) searching for a new job (in another field) in the next year.
) Responses for both included a 7-point likert scale of: very strongly disagree, strongly disagree, disagree neutral, agree, strongly agree, very strongly agree.
Both questions were dichotomized into "agree", "strongly agree", and "very strongly" vs. all other responses.
|
Baseline (0 days); at follow-up (90 days)
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Visits to the Emergency Department
Time Frame: Baseline (0 days); at follow-up (90 days)
|
All-cause emergency department visits to any emergency department
|
Baseline (0 days); at follow-up (90 days)
|
|
Number of Readmissions to the Hospital
Time Frame: Baseline (0 days); at follow-up (90 days)
|
All-cause readmissions to any hospital
|
Baseline (0 days); at follow-up (90 days)
|
|
Change in Preventable 911 Calls
Time Frame: Baseline (0 days); at follow-up (90 days)
|
Preventable 911 calls were assessed with 2-close ended questions that we previously used among HHAs: "I have called 911 when that could have been prevented if I had been able to reach my supervisor/the nurse."
and "I have called 911 when that could have been prevented if my supervisor and I had been able to reach the client's doctor."
Responses for both included a 7-point Likert scale of: very strongly disagree, strongly disagree, disagree neutral, agree, strongly agree, very strongly agree.
Both questions dichotomized into "agree", "strongly agree", and "very strongly" vs. all other responses.
|
Baseline (0 days); at follow-up (90 days)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Madeline R Sterling, MD, MPH, MS, Weill Medical College of Cornell University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 19-08020553
- K23HL150160-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.